Valais start-up Precise Health wins CHF 40,000 Venture Kick prize
Precise Health, a biotech start-up based at the Energypolis Campus in Sion, has won phase 2 of the national Venture Kick competition.
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Siegfried selected the canton of Valais for its new global R&D center due to its strategic importance within the company’s network.
Haut-Valais SME ten23 health opens a new, cutting-edge facility in Viège
The company ten23 health has opened a new, cutting-edge facility in the town in Haut-Valais.
Valaisan SME Lugaia rides the wave of success with its niche products
Company owner Viktor Schnyder explains what makes Lugaia tick and how the company benefits from its location in the Valais.
Will start-up Curio Biotech soon mark an end to animal experiments?
Curio Biotech, a young firm based in the BioArk in Visp, uses human tissue to test cosmetics and medicines.
The remarkable chemical-pharmaceutical industry in the canton of Valais
For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation with economic growth.
Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry
Siegfried’s success in Evionnaz is largely attributed to the expertise and flexibility of its workforce.
Debiopharm invests CHF 30 million in Valais amidst workforce surge
Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.
Valsynthèse, 40 years of innovation in the canton of Valais
Valsynthèse, the ‘fine chemistry’ business unit of the Société Suisse des Explosifs, celebrates four decades of steering innovative chemical solutions in Valais.
BioArk’s third building in Monthey has just been inaugurated and is already almost full!
The Monthey-based technology site, which celebrates its 20th anniversary this year, inaugurated its third building on Friday.